Frank Mendrzyk

Frank Mendrzyk has an extensive work experience in the pharmaceutical industry. Frank started their career at Roche Pharmaceuticals in 2006 as a Sales Representative for Tarceva/Avastin, and later became a Product Manager for Herceptin. Frank then took on the role of Teamleader and Leader Biomarker Field Force Oncology, where they established a new business area focused on delivering a medical marketing mix to customers. In 2013, Frank became the Pipeline Product Strategy Lead Oncology, responsible for coordinating the activities of new pipeline products and companion diagnostics. Frank also served as the Brand Lead for Atezolizumab and Alectinib, with full responsibility for the brands' profit and loss. In 2018, they joined Indivior as the Head of Marketing.

Frank Mendrzyk earned their Doctor of Philosophy (PhD) in Molecular Biology from the University of Heidelberg / German Cancer Research Center (DKFZ) Heidelberg from 2002 to 2006. Prior to that, they obtained a Diploma (Master) in Molecular Biology from Justus Liebig University Giessen from 1997 to 2002. Frank completed their Abitur (equivalent to A-levels) at Mauritius Gymnasium from 1991 to 1996.